Health Care Insider Trading
Insider buying and selling across Pharmaceuticals, Biotech & Health Care Services. Browse industries, recent Form 4 filings, and sector performance trends.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling across Pharmaceuticals, Biotech & Health Care Services. Browse industries, recent Form 4 filings, and sector performance trends.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative sector performance with the overall market movement removed. When the line rises above 100, the sector is outperforming the market; below 100 means underperforming. This is calculated using market-orthogonal factor returns via weighted least squares (WLS) regression, isolating pure sector-specific trends.
Absolute shows the total cumulative return of the sector including market movement. This reflects what an investor actually experienced — a sector can show strong absolute gains even while underperforming the market in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes a sector behave the way it does and may reflect the conditions insiders are responding to.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | EWTX Edgewise Therapeutics, Inc. | Donovan Joanne M. | CMO | Sell | 55,230 | $37.88 | $2,092,062.91 | -86.3% | - | - | |
| May 5, 2026 | IRMD Iradimed Corporation | Susi Roger E. | CEO, President, Chairman | Sell | 7,500 | $85.71 | $642,861.82 | - | - | - | |
| May 4, 2026 | ARQT Arcutis Biotherapeutics, Inc. | Matsuda Masaru | See Remarks | Sell | 8,256 | $23.31 | $192,415.26 | -3.1% | - | - | |
| May 4, 2026 | OPCH Option Care Health, Inc. | Sethna Meenal | Chief Financial Officer | Buy | 16,225 | $20.16 | $327,074.91 | +19.8% | - | - | |
| May 4, 2026 | TRDA Entrada Therapeutics, Inc. | Sethuraman Natarajan | President, Research &Develop. | Sell | 25,907 | $15.39 | $398,809.77 | -10.7% | - | - | |
| May 4, 2026 | TRDA Entrada Therapeutics, Inc. | Dowden Nathan J | President &COO | Sell | 15,000 | $15.33 | $229,953.00 | -7.0% | - | - | |
| May 4, 2026 | OPCH Option Care Health, Inc. | Rademacher John Charles | Chief Executive Officer | Buy | 12,500 | $21.18 | $264,706.25 | +1.8% | - | - | |
| May 4, 2026 | NTRA Natera, Inc. | Brophy Michael Burkes | Chief Financial Officer | Sell | 795 | $208.79 | $165,984.26 | -0.7% | - | - | |
| May 4, 2026 | ACAD Acadia Pharmaceuticals Inc. | Kihara James | Principal Accounting Officer | Sell | 1,332 | $21.79 | $29,024.28 | -4.4% | - | - | |
| May 4, 2026 | ACAD Acadia Pharmaceuticals Inc. | Schneyer Mark C. | EVP, Chief Financial Officer | Sell | 3,506 | $21.79 | $76,395.74 | -5.0% | - | - | |
| May 4, 2026 | EW Edwards Lifesciences Corporation | Lippis Daniel J. | Cvp, Tavr | Sell | 2,038 | $83.49 | $170,160.29 | -1.9% | - | - | |
| May 4, 2026 | HOWL Werewolf Therapeutics, Inc. | Evnin Luke | Director | Sell | 274,619 | $0.72 | $198,309.62 | -5.0% | - | - | |
| May 1, 2026 | AVTR Avantor, Inc. | Dingemans Simon | Director | Buy | 25,000 | $8.14 | $203,500.00 | New | - | - | |
| May 1, 2026 | CBLL Ceribell, Inc. | Woo Raymond | Chief Technology Officer | Sell | 11,104 | $20.44 | $226,928.18 | -1.8% | - | - | |
| May 1, 2026 | XERS Xeris Biopharma Holdings, Inc. | Hecht Beth | See Remarks | Sell | 16,667 | $6.23 | $103,805.41 | -1.4% | - | - | |
| May 1, 2026 | NTRA Natera, Inc. | Moshkevich Solomon | President, Clinicaldiagnostics | Sell | 3,405 | $203.69 | $693,559.95 | -0.3% | - | - | |
| May 1, 2026 | BFLY Butterfly Network, Inc. | Carlson Megan | CAO And SVP, Finance | Sell | 110,422 | $4.75 | $524,394.08 | -17.9% | - | - | |
| May 1, 2026 | ALKS Alkermes Plc | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sell | 9,000 | $33.40 | $300,559.50 | -10.0% | - | - | |
| May 1, 2026 | TNGX Tango Therapeutics, Inc. | Crystal Adam | President, R&D | Sell | 27,000 | $21.23 | $573,097.33 | -10.4% | - | - | |
| May 1, 2026 | NTRA Natera, Inc. | Sheena Jonathan | Director, Co-founder | Sell | 107 | $206.16 | $22,059.12 | - | - | - | |
| May 1, 2026 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | 4,170 | $13.12 | $54,694.20 | -1.4% | - | - | |
| May 1, 2026 | NTRA Natera, Inc. | Rabinowitz Daniel | Sec. And Chief Legal Officer | Sell | 330 | $206.16 | $68,032.80 | -0.1% | - | - | |
| May 1, 2026 | NTRA Natera, Inc. | Chapman Steven Leonard | CEO And President | Sell | 902 | $206.16 | $185,956.32 | -0.6% | - | - | |
| May 1, 2026 | GEHC Ge Healthcare Technologies Inc. | Saccaro James | Chief Financial Officer | Buy | 3,310 | $60.60 | $200,585.01 | +3.9% | - | - | |
| May 1, 2026 | PCVX Vaxcyte, Inc. | Wassil Jim | Chief Operating Officer | Sell | 2,250 | $56.83 | $127,869.75 | -1.4% | - | - |
65 companies
$31.4M / $195.4M
3 companies
$59.7M
9 companies
$223K / $27.7M
6 companies
$2.7M / $20.2M
19 companies
$1.8M / $14.4M
4 companies
$926K / $6.8M